SK ChemicalsLtd Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

SK ChemicalsLtdDie Umsatzerlöse des Unternehmens werden voraussichtlich um 1.6% pro Jahr zurückgehen, während die jährlichen Gewinne voraussichtlich um 41.2% pro Jahr wachsen werden. Der Gewinn pro Aktie wird voraussichtlich um 34.1% pro Jahr wachsen. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 2% betragen.

Wichtige Informationen

41.2%

Wachstumsrate der Gewinne

34.1%

EPS-Wachstumsrate

Chemicals Gewinnwachstum	68.3%
Wachstumsrate der Einnahmen	-1.6%
Zukünftige Eigenkapitalrendite	2.0%
Analystenabdeckung	Low
Zuletzt aktualisiert	06 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

We Think That There Are More Issues For SK ChemicalsLtd (KRX:285130) Than Just Sluggish Earnings

Mar 22

There Is A Reason SK Chemicals Co.,Ltd's (KRX:285130) Price Is Undemanding

Mar 15

We Think SK ChemicalsLtd's (KRX:285130) Robust Earnings Are Conservative

Mar 29

Should You Think About Buying SK Chemicals Co.,Ltd. (KRX:285130) Now?

Mar 24

Imagine Holding SK ChemicalsLtd (KRX:285130) Shares While The Price Zoomed 499% Higher

Mar 02

An Intrinsic Calculation For SK Chemicals Co.,Ltd. (KRX:285130) Suggests It's 21% Undervalued

Feb 08

SK Chemicals Co.,Ltd. (KRX:285130) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Jan 20

What Type Of Shareholders Own The Most Number of SK Chemicals Co.,Ltd. (KRX:285130) Shares?

Dec 30

When Should You Buy SK Chemicals Co.,Ltd. (KRX:285130)?

Dec 09

Did You Miss SK ChemicalsLtd's (KRX:285130) Whopping 729% Share Price Gain?

Nov 19

Gewinn- und Umsatzwachstumsprognosen

KOSE:A285130 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (KRW Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	1,706,000	73,000	N/A	246,000	1
12/31/2025	1,693,200	12,400	-6,000	178,500	2
12/31/2024	1,637,000	-4,950	-266,000	504,000	2
6/30/2024	1,807,846	35,197	-168,228	222,647	N/A
3/31/2024	1,765,283	15,929	-247,563	175,823	N/A
12/31/2023	1,748,778	35,689	-253,836	146,064	N/A
9/30/2023	1,794,436	126,293	-450,231	41,401	N/A
6/30/2023	1,645,542	114,243	-568,738	-109,260	N/A
3/31/2023	1,775,509	170,141	-490,438	-72,730	N/A
12/31/2022	1,829,191	191,266	-487,999	-186,536	N/A
9/30/2022	2,123,241	214,870	-116,892	122,870	N/A
6/30/2022	2,209,667	237,197	-57,927	145,968	N/A
3/31/2022	2,134,811	249,610	4,324	170,726	N/A
12/31/2021	2,089,632	270,006	362,192	509,316	N/A
9/30/2021	1,624,068	219,644	168,295	301,840	N/A
6/30/2021	1,457,229	197,761	196,194	302,769	N/A
3/31/2021	1,319,192	139,871	320,393	416,907	N/A
12/31/2020	1,198,781	89,080	153,469	247,010	N/A
9/30/2020	1,173,655	38,647	88,992	179,371	N/A
6/30/2020	1,105,648	-5,652	60,643	162,730	N/A
3/31/2020	1,112,535	615	-20,140	99,927	N/A
12/31/2019	1,112,919	-17,420	-5,520	122,135	N/A
9/30/2019	1,155,857	-43,090	-25,916	95,654	N/A
6/30/2019	1,248,197	-15,342	-6,781	106,471	N/A
3/31/2019	1,306,638	-11,800	-3,695	86,041	N/A
12/31/2018	1,367,719	6,028	-16,905	67,370	N/A
12/31/2017	1,054,037	-102,431	N/A	-128,022	N/A
12/31/2016	1,146,626	11,687	N/A	N/A	N/A
12/31/2015	1,039,864	119,950	N/A	N/A	N/A
12/31/2014	1,232,854	-20,128	N/A	N/A	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: A285130Das prognostizierte Gewinnwachstum (41.2% pro Jahr) liegt über der Sparquote (2.7%).

Ertrag vs. Markt: A285130Die Erträge des Unternehmens (41.2% pro Jahr) werden voraussichtlich schneller wachsen als der Markt KR (28% pro Jahr).

Hohe Wachstumserträge: A285130Es wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: A285130Die Einnahmen des Unternehmens werden in den nächsten 3 Jahren voraussichtlich zurückgehen (-1.6% pro Jahr).

Hohe Wachstumseinnahmen: A285130Die Einnahmen des Unternehmens werden in den nächsten drei Jahren voraussichtlich zurückgehen (-1.6% pro Jahr).

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: A285130Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (2%).

SK ChemicalsLtd Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates increase by 46%

Consensus EPS estimates increase by 1,301%

Price target decreased to ₩130,000

Price target increased to ₩333,333

Price target increased to ₩333,333

Price target raised to ₩513,333

Recent updates

What You Can Learn From SK Chemicals Co.,Ltd's (KRX:285130) P/E

Consensus EPS estimates increase by 46%

We Think SK ChemicalsLtd (KRX:285130) Can Stay On Top Of Its Debt

SK Chemicals Launches ECOTRIA CLARO 300 with Improved Recyclability

SK Chemicals Co.,Ltd(KOSE:A285130) dropped from FTSE All-World Index (USD)

Consensus EPS estimates increase by 1,301%

SK Chemicals Co.,Ltd's (KRX:285130) Price Is Out Of Tune With Revenues

Upcoming dividend of ₩400 per share

New major risk - Revenue and earnings growth

First quarter 2024 earnings released: ₩214 loss per share (vs ₩816 profit in 1Q 2023)

SK chemicals Unveils Blueprint for Circular Recycle™ and Solutions

SK Chemicals, Dongsung Chemical, and Black Yak Collaborate on Commercializing Sustainable Footwear

We Think That There Are More Issues For SK ChemicalsLtd (KRX:285130) Than Just Sluggish Earnings

Full year 2023 earnings released: EPS: ₩2,072 (vs ₩9,910 in FY 2022)

There Is A Reason SK Chemicals Co.,Ltd's (KRX:285130) Price Is Undemanding

Upcoming dividend of ₩1,100 per share at 2.2% yield

Third quarter 2023 earnings released: EPS: ₩2,441 (vs ₩1,815 in 3Q 2022)

Glenwood Private Equity signed a memorandum of understanding to acquire the Pharmaceutical business of SK Chemicals Co.,Ltd (KOSE:A285130).

New minor risk - Profit margin trend

Upcoming dividend of ₩400 per share at 1.5% yield

First quarter 2023 earnings released: EPS: ₩816 (vs ₩1,881 in 1Q 2022)

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased to ₩130,000

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Price target increased to ₩333,333

Price target increased to ₩333,333

Upcoming dividend of ₩1,333 per share

Metrica Partners Calls for a Strategic Review at SK Chemicals

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Metrica Partners Sends Letter to SK Chemicals

We Think SK ChemicalsLtd's (KRX:285130) Robust Earnings Are Conservative

Full year 2020 earnings released: EPS ₩621 (vs ₩1,318 loss in FY 2019)

Should You Think About Buying SK Chemicals Co.,Ltd. (KRX:285130) Now?

Investor sentiment deteriorated over the past week

SK Chemicals Co.,Ltd., Annual General Meeting, Mar 31, 2021

Investor sentiment deteriorated over the past week

New 90-day low: ₩347,000

Imagine Holding SK ChemicalsLtd (KRX:285130) Shares While The Price Zoomed 499% Higher

Daejung Chemicals & Metals Co.,Ltd. (KOSDAQ:A120240) acquired 50% in Sk Chemicals Daejung Co,. Ltd from SK Chemicals Co.,Ltd. (KOSE:A285130) for KRW 6 billion.

Price target raised to ₩513,333

An Intrinsic Calculation For SK Chemicals Co.,Ltd. (KRX:285130) Suggests It's 21% Undervalued

New 90-day high: ₩462,500

SK Chemicals Co.,Ltd. (KRX:285130) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Standigm Inc. and K Chemicals Co., Ltd. Repurpose FDA-approved Drug into Rheumatoid Arthritis Candidate and Apply for Patent through their Open Innovation Partnership

What Type Of Shareholders Own The Most Number of SK Chemicals Co.,Ltd. (KRX:285130) Shares?

Upcoming Dividend of ₩450 Per Share

When Should You Buy SK Chemicals Co.,Ltd. (KRX:285130)?

Analysts increase EPS estimates to ₩17,352

Did You Miss SK ChemicalsLtd's (KRX:285130) Whopping 729% Share Price Gain?

Analysts update estimates

New 90-day high: ₩449,500

Kyung-joo Park and other investors acquired 16.03% stake in JSI Co. Ltd. from SK Chemicals Co.,Ltd. (KOSE:A285130) for KRW 0.04 million.

New 90-day high - ₩314,000

Price target raised to ₩183,750

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken